• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Protein Therapeutics: Monoclonal Antibodies, Plasma Proteins, Vaccines, and Other Treatments, Global Market

$995.00 – $1,990.00

Clear
SKU: KLI1646601 Categories: Biotechnology Market Research, Proteomics Pages: 250
  • Description
  • Table of Contents
  • Latest reports

Description

The substances utilized for what is commonly referred to as ‘protein therapeutics’ have one thing in common — they are all composed primarily of á-amino acids; and these á-amino acids are linked together by a distinct chemical bond known as a “peptide” bond. Used in a variety of areas of medicine, they are among the most interesting pharmaceutical markets.

Above-Average Growth Rates

What makes protein therapeutics interesting? The market for protein-based therapeutics is one that is significant in its size and growing at a rate that is well above what one would call “average” for the therapeutics/pharmaceuticals industry. This makes them a continual topic of interest for researchers examining the pharmaceutical markets. Protein Therapeutics: (Monoclonal Antibodies, Plasma Proteins, Vaccines and Other Treatments) takes a detailed look at this market

The substances detailed in this report include:

 

  • Monoclonal Antibodies
  • Antithrombins
  • Cytokines
  • Growth Hormones
  • Hematopoietics
  • Insulin
  • Plasma Proteins
  • Vaccines
  • Miscellaneous

 

For each of these categories, market forecasts to 2012 are provided.

A Thriving Field with Abundant Competition

At the present time, there are at least 213 companies active in various aspects of protein-based therapeutics development. This is at, or greater than, the saturation level for the industry at this time. Presently, the industry is at equilibrium — companies at the lower end leaving and entering at about the same rate and a small number of protein-based therapeutics companies being acquired by the more-established participants.

A Report That Answers Key Questions about the Market

Dr. Kenneth Krul, PhD has surveyed the marketplace and in this volume reviews the key findings and conclusions about the current state of protein therapeutics. The report features forecasts for the main groups of protein therapeutics. Among the questions answered in this report:

  • How large is the market; how fast is the market growing; and is such growth sustainable?
  • What does the pipeline of products that are expected to sustain this growth look like?
  • To what extent is the growth in this market dependent on production introduction versus price-point for these products?
  • Is the development pipeline filled with similar products or direct alternatives such that product competition will be strong enough to significantly affect price-point?
  • What is the industry structure like? What changes can be expected in the structure of the industry and how will these changes affect market size and growth?

Table of Contents

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Scope and Methodology
  • Market Analysis
  • Trends and Considerations

CHAPTER TWO: PEPTIDES, PROTEINS, ENZYMES AND ANTIBODIES

  • Peptides
  • Tachykinin Peptides
  • Vasoactive Intestinal Peptides
  • Pancreatic Polypeptide-Related Peptides
  • Opioid Peptides
  • Calcitonin Peptides
  • Other Peptides
  • Proteins
  • Enzymes
  • Coenzymes
  • Antibodies
  • Allotype

CHAPTER THREE: CLINICAL APPLICATIONS OF APPLICATIONS OF PROTEIN-BASED THERAPEUTICS

  • Advantages of Protein Therapeutics
  • Group I: Enzymes and Regulatory Proteins
  • Group II: Targeted Proteins
  • Group III:
  • Toward the Future

CHAPTER FOUR: MARKET ANALYSIS

  • Growth Rate
  • Forecast
  • Trending By Product Class
  • Vaccines Market Forecast
  • Antithrobins Market Forecast
  • Hematopoietics Market Forecast
  • Insulin Market Forecast
  • Growth Hormones Market Forecast
  • Plasma Proteins Market Forecast
  • Trending by Product Class
  • Pipeline

CHAPTER FIVE: COMPANY SNAPSHOTS

  • Agennix
  • Altus Pharmaceuticals
  • Amgen
  • Amylin Pharmaceuticals
  • Biogen IDEC
  • BioMarin Pharmaceutical, Inc.
  • Cell Genesys, Inc
  • Eli Lilly & Company
  • Genentech, Inc.
  • Genzyme Corporation
  • Human Genome Sciences
  • Medarex
  • Neose Technologies, Inc.
  • Novo Nordisk, Inc (USA)
  • Regeneron Pharmaceuticals, Inc.
  • Xoma, Ltd.

CHAPTER SIX: CONCLUSIONS AND STRATEGIC IMPLICATIONS

  • First Conclusion
  • Second Conclusion
  • Third Conclusion
  • Fourth Conclusion
  • Fifth Conclusion
  • Sixth Conclusion
  • Seventh Conclusion
  • Eighth Conclusion
  • Ninth Conclusion
  • Tenth Conclusion

APPENDIX A: GLOSSARY

TABLE OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Table 1-1: Estimated Global Market for Protein-Based Therapeutics by Major Product Class: 2008 – 2018
  • Figure 1-1: Trending in the Global Market for Protein-Based Therapeutics: 2008 – 2018
  • Figure 1-2: Trending in the Protein-Based Therapeutics Global Market by Product Class: 2008 – 2018

CHAPTER TWO: PEPTIDES, PROTEINS, ENZYMES AND ANTIBODIES

  • Table 2-1: The Naturally Occurring Amino Acids
  • Table 2-2: Significant Peptides in Biological Functions
  • Table 2-3: Key Features of Immunoglobulin Isotypes
  • Table 2-4: Immunoglobulin Functional Properties

CHAPTER THREE: CLINICAL APPLICATIONS OF APPLICATIONS OF PROTEIN-BASED THERAPEUTICS

  • Table 3-1: Replacement Protein Therapeutics: Subgroup Ia
  • Table 3-2: Augmenting Protein Therapeutics: Subgroup Ib
  • Table 3-3: Protein Therapeutics with a Novel Function Activity: Subgroup Ic
  • Table 3-4: Protein Vaccines: Subgroup IIa
  • Table 3-5: Drug Delivery Protein Therapeutics: Subgroup IIb
  • Table 3-6: Protein Vaccines: Group III
  • Figure 3-1: Biotechnology-Based Therapeutics in Development by Product Category: 2008 (Growth Factors, Interferons, Interleukins, Monoclonal Antibodies (mAbs), Recombinant Hormones/Proteins, Vaccines, Others)
  • Figure 3-2: Biotechnology-Based Therapeutics in Development by Protein and Non-Protein Category: 2008
  • Figure 3-3: Biotechnology-Based Therapeutics in Development by Clinical Application (Disease State): 2008
  • Table 3-7: Protein-Based Therapeutics in Development: 2008
  • Figure 3-4: Distribution of Protein-Based Therapeutics in Development by Orphan and Non-Orphan Drug Categories: 2008
  • Figure 3-5: Distribution of Protein-Based Therapeutics in Development Type: 2008
  • Figure 3-6: Distribution of Protein-Based Vaccines in Development by Recombinant and Non-Recombinant Categories: 2008

CHAPTER FOUR: MARKET ANALYSIS

  • Table 4-1: Estimated Global Market for Protein-Based Therapeutics by Major Product Class: 2008 – 2018
  • Figure 4-1 : Trending in the Global Market for Protein-Based Therapeutics: 2008 – 2018
  • Figure 4-2: Trending in the Protein-Based Therapeutics Global Market by Product Class: 2008 – 2018
  • Figure 4-3: Trending in the Protein-Based Therapeutics Global Market by Product Class: 2008 – 2018
  • Figure 4-4: Biopharmaceutical Approvals by the United States FDA: 1988 – 2007
  • Table 4-2: Biopharmaceuticals Approved by the FDA: 2006 – 2008
  • Table 4-3: Global Markets for Cytokines, Vaccines and Hematopoietic Factors: 2008 – 2018
  • Table 4-4: Companies Engaged in Protein-Based Therapeutics Development

 

    The Worldwide Market for Mass Spectrometry in Clinical Labs, 2024
    September 11, 2024
    Worldwide Sequencer Market, 2023-2028
    August 8, 2024
    The Worldwide Market for Liquid Biopsy, 6th Edition
    December 29, 2023
    The Market for RNA Sequencing, 3rd Edition
    September 8, 2023

Related products

  • Placeholder image

    Stem Cell Therapeutics Markets

    $995.00 – $5,000.00
  • Placeholder image

    U.S. Markets in Analytical Chip Technology: Gene, Protein, Tissue, Cell, and Microbiological Microarrays, 2nd Ed.

    $3,500.00 – $7,000.00
  • Placeholder image

    Liquid Chromatography Markets (LC, HPLC and UHPLC)

    $1,995.00 – $3,990.00
  • Placeholder image

    Glycosylated Protein Therapeutics – A Market Briefing

    $795.00 – $1,590.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  June 24, 2025
  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Glucose Testing MarketsBiophotonics – A Strategic Assessment of Photonics Technologies for Biomedical...
Scroll to top